Commercialization And Logistics
-
Safety And Efficiency Of Source Material Collection
8/18/2023
Expert CTO's detail how automation improves safety and efficiency when collecting source material.
-
Market Demand For AAV Vectors
11/13/2023
Here, Dave Maheu, VP, Head of Process & Analytical Development at Candel Therapeutics and Curran Simpson, Chief Operating Officer at REGENXBIO detail the key factors driving the adeno associated virus manufacturing market.
-
Optimize Cell Isolation And Activation For Flexibility And Scalability
11/13/2023
Learn about a first-of-its-kind platform technology that enables isolation and activation of T cells in one step using an active release mechanism for clinical trial or commercial manufacturing.
-
Driving Down COGS Audience Q&A
8/18/2023
Expert panelists provide detailed answers to questions submitted in real time by our registrants providing insightful responses regarding analytical challenges to automation, test automation, and more.
-
Process Liquids And Buffers Offering
5/2/2024
Whether you are a researcher, scientist, or industry professional, this video will provide valuable insights into our large volume liquids manufacturing capabilities.
-
Regulatory Compliance And Viral Vectors
11/13/2023
Hear from experts who detail the specific regulatory challenges for advanced therapies, as well as how the regulatory requirements differ in early research and development in academia and in industrial vector production.
-
Defining The CMC / Clinical Relationship For Allogeneic Cell Therapies
5/6/2024
During this segment, Nguyen and Wagner define why the relationship between CMC and Clinical is so critical, and they also explain what a mutually beneficial partnership between CMC and Clinical looks like.
-
Supply Chain And Operational Challenges Facing mRNA
1/29/2024
Explore some of the biggest supply chain challenges facing mRNA cancer therapeutics and what short-term solutions may exist, starting with Chain of Custody/Chain of Identity.